Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'POU domain, class 2, transcription factor 2' and Ligand = 'BDBM350831'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
POU domain, class 2, transcription factor 2 (Homo sapiens (Human))	BDBM350831 (US9795602, Compound 31) Show SMILES Oc1c2C(=O)N(CC(F)(F)F)[C@H]3COCC[C@H]3n2cc(C(=O)NCc2c(F)cc(F)cc2F)c1=O |r| Show InChI InChI=1S/C21H17F6N3O5/c22-9-3-12(23)10(13(24)4-9)5-28-19(33)11-6-29-14-1-2-35-7-15(14)30(8-21(25,26)27)20(34)16(29)18(32)17(11)31/h3-4,6,14-15,32H,1-2,5,7-8H2,(H,28,33)/t14-,15+/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
GILEAD SCIENCES, INC. US Patent					Assay Description The dose dependent inhibition of OCT2 mediated uptake of a model substrate 14C-Tetraethylammonium (TEA) by test compounds was studied in wild-type an...				US Patent US9795602 (2017) BindingDB Entry DOI: 10.7270/Q2K35WTB
					More data for this Ligand-Target Pair